A Comparison of the Blood Pressure Changes of Lumiracoxib With Those of Ibuprofen and Naproxen

The 52‐week Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET) investigated the gastrointestinal and cardiovascular safety profile of lumiracoxib 400 mg once daily compared with 2 traditional nonsteroidal anti‐inflammatory drugs (NSAIDs): ibuprofen 800 mg 3 times daily and napr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Hypertens (Greenwich)
Main Authors: Farkouh, Michael E., Verheugt, Freek W. A., Ruland, Sean, Kirshner, Howard, Jeger, Raban, Gitton, Xavier, Krammer, Gerhard, Stricker, Kirstin, Sallstig, Peter, Mellein, Bernhard, Matchaba, Patrice, Chesebro, James H.
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Inc 2008
Assuntos:
Original Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8109916/
https://ncbi.nlm.nih.gov/pubmed/18772641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2008.07802.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados